Showing results (321-330 of 416) with videos related to
Sort By:
Pageof 42
Rheumatology International|February 11, 2020
Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studiesMichaela Koehm, Matthew J McIntosh, Michael W Hofmann, et al.The Journal of Biological Chemistry|July 4, 1997
Induced mutant mice expressing lipoprotein lipase exclusively in muscle have subnormal triglycerides yet reduced high density lipoprotein cholesterol levels in plasmaS Levak-Frank, P H Weinstock, T Hayek, et al.Circulation Research|May 3, 2014
Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiationJohannes Weirather, Ulrich D W Hofmann, Niklas Beyersdorf, et al.Pharmacopsychiatry|March 21, 2012
Antipsychotic drugs predominate in pharmacotherapy of nursing home residents with dementiaM Huber, M Kölzsch, M A Rapp, et al.BMC Neurology|March 23, 2020
Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case reportJoline M Fan, David A Solomon, Giselle Y López, et al.Proceedings of the National Academy of Sciences of the United States of America|January 10, 2025
The return of stagnant slab recorded by intraplate volcanismZhong-Biao Zhou, Li-Hui Chen, Zhou-Chuan Huang, et al.Experimental Lung Research|June 13, 2001
Comparison of clearance of particles inhaled with bolus and extremely slow inhalation techniquesM Svartengren, K Sommerer, G Scheuch, et al.Science Advances|June 1, 2022
Archean cratonic mantle recycled at a mid-ocean ridgeChuan-Zhou Liu, Henry J B Dick, Ross N Mitchell, et al.Biointerphases|April 8, 2014
Polarizing cytoskeletal tension to induce leader cell formation during collective cell migrationSebastian Rausch, Tamal Das, Jérôme R D Soiné, et al.Clinical and Experimental Rheumatology|January 9, 2023
Sustained effectiveness and safety of subcutaneous tocilizumab over two years in the ARATA observational studyFrank Behrens, Gerd-Rudiger Burmester, Michael W Hofmann, et al.Pageof 42